Morrisville drugmaker plots biosafety facility in major strategy shift

A biotech in Morrisville is building a new research facility and pursuing a monkeypox vaccine as it tries to position itself as a leader in the biodefense space.

Previous Sonoma Bio plans move to F5's former Seattle waterfront campus
Next The Punch List: New Clintonville apartments, Bridge Park update and more in our weekly real estate roundup